Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Cancer|May 15, 1996
Is paclitaxel and cisplatin a cost-effective first-line therapy for advance ovarian carcinoma?A Covens, S Boucher, K Roche, et al.Gynecologic Oncology|October 1, 1993
Differences in the morbidity of radical hysterectomy between gynecological oncologistsA Covens, B Rosen, A Gibbons, et al.Gynecologic Oncology|January 1, 1997
A phase II study of leuprolide in advanced/recurrent endometrial cancerA Covens, G Thomas, P Shaw, et al.Gynecologic Oncology|March 21, 2007
Intraperitoneal chemotherapy for patients with advanced ovarian cancer: a review of the evidence and standards for the delivery of careM Fung-Kee-Fung, D Provencher, B Rosen, et al.Gynecologic Oncology|December 26, 2001
How important is removal of the parametrium at surgery for carcinoma of the cervix?A Covens, B Rosen, J Murphy, et al.Gynecologic Oncology|May 2, 2001
Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 yearsA Covens, B Rosen, J Murphy, et al.BJOG : an International Journal of Obstetrics and Gynaecology|June 3, 2009
Defining the surgical management of suspected early-stage ovarian cancer by estimating patient numbers through alternative management strategiesJ Warwick, E Vardaki, N Fattizzi, et al.Cancer|December 26, 2001
Does histology influence prognosis in patients with early-stage cervical carcinoma?D Grisaru, A Covens, B Chapman, et al.Gynecologic Oncology|November 1, 1995
Does aggressive therapy improve survival in suboptimal stage IIIc/IV ovarian cancer? A Canadian-American comparative studyS LoCoco, A Covens, M Carney, et al.British Journal of Cancer|December 25, 2013
Assessment of endometrial sampling as a predictor of final surgical pathology in endometrial cancerL Helpman, R Kupets, A Covens, et al.Pageof 4